
GC39634
Orelabrutinib
Also known as 2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpiperidin-4-yl)pyridine-3-carboxamide
Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity· Orelabrutinib prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, inhibiting the growth of malignant B-cells that overexpress BTK
ChemicalCAS1655504-04-3MW427.5FormulaC26H25N3O3
- CAS number
- 1655504-04-3
- Molecular weight
- 427.5
- Formula
- C26H25N3O3
- Solubility
- DMSO: 250 mg/mL (584·80 mM)
- InChIKey
- MZPVEMOYADUARK-UHFFFAOYSA-N
- Catalogue number
- GC39634
- Brand
- GLPBIO
Computed properties PubChem CID 91667513 · XLogP 3.6 · TPSA 85.5 Ų · H-bond donors 1
- XLogP
- 3.6
- TPSA
- 85.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 6
- Heavy atoms
- 32
SMILES C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4
Computed descriptors from PubChem (CID 91667513), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il